N, B., S, C., Y, F., L, P., S, H., G, C., . . . DM, S. (2024). Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 78(2), 461. https://doi.org/10.1093/cid/ciad584
Chicago Style (17th ed.) CitationN, Brousseau, et al. "Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 78, no. 2 (2024): 461. https://doi.org/10.1093/cid/ciad584.
MLA (9th ed.) CitationN, Brousseau, et al. "Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 78, no. 2, 2024, p. 461, https://doi.org/10.1093/cid/ciad584.